Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2019-04-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
2018年度审计报告
Regulatory Filings
2019-04-28 Chinese
关于召开2018年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2018 Annual General Meeting (AGM) of 金宇生物技术股份有限公司, including the date, voting procedures, agenda items, and instructions for shareholders. It includes information about the meeting logistics, voting methods (including cumulative voting), and proxy forms. The document does not contain financial statements or results but is focused on informing shareholders about the upcoming AGM and the matters to be voted on. This matches the description of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length (6419 characters) and content confirm it is not a brief announcement but a full AGM notice with detailed procedural information. Therefore, the correct classification is AGM Information (AGM-R).
2019-04-28 Chinese
2018年度审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2018年度审计委员会履职情况报告" which translates to "2018 Annual Audit Committee Performance Report." It details the activities and oversight performed by the audit committee during the year 2018, including meetings held, evaluation of external auditors, internal audit guidance, review of financial reports, and internal control assessments. The document is a report from the audit committee on their supervisory and audit-related work rather than the full annual report or standalone audit report itself. It does not contain full financial statements or detailed audit opinions but rather a summary of audit committee activities and evaluations. Given the focus on audit committee duties and oversight, this fits best under the category of Audit Report / Information (AR), which includes audit reports and related supervisory information excluding full annual reports. The document length is 3166 characters, which is relatively short but contains substantive content about audit committee work, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2018
2019-04-28 Chinese
2018年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the 2018 annual report summary of 金宇生物技术股份有限公司 (Jinyu Biotechnology Co., Ltd.). It contains detailed financial data for the year 2018, including total assets, revenue, net profit, quarterly financial data, shareholder information, and business overview. It also mentions the audit report with an unqualified opinion. The document is a comprehensive summary of the company's yearly performance and financial condition, which aligns with the definition of an Annual Report (10-K). The length is about 5005 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or a brief summary. Therefore, the document should be classified as an Annual Report (10-K). FY 2018
2019-04-28 Chinese
经世律师事务所关于金宇生物技术股份有限公司终止实施2017年度限制性股票股权激励计划并回购注销已授予但尚未解锁限制性股票相关事项之法律意见书
Regulatory Filings
2019-04-28 Chinese
独立董事关于以集中竞价交易方式回购股份的独立意见
Regulatory Filings
2019-04-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.